249 related articles for article (PubMed ID: 12967950)
1. 2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.
Neelands TR; Burgard EC; Uchic ME; McDonald HA; Niforatos W; Faltynek CR; Lynch KJ; Jarvis MF
Br J Pharmacol; 2003 Sep; 140(1):202-10. PubMed ID: 12967950
[TBL] [Abstract][Full Text] [Related]
2. Competitive antagonism of recombinant P2X(2/3) receptors by 2', 3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP).
Burgard EC; Niforatos W; van Biesen T; Lynch KJ; Kage KL; Touma E; Kowaluk EA; Jarvis MF
Mol Pharmacol; 2000 Dec; 58(6):1502-10. PubMed ID: 11093790
[TBL] [Abstract][Full Text] [Related]
3. Agonist antagonist interactions at the rapidly desensitizing P2X3 receptor.
Helms N; Kowalski M; Illes P; Riedel T
PLoS One; 2013; 8(11):e79213. PubMed ID: 24223907
[TBL] [Abstract][Full Text] [Related]
4. Agonist-dependence of recovery from desensitization of P2X(3) receptors provides a novel and sensitive approach for their rapid up or downregulation.
Sokolova E; Skorinkin A; Fabbretti E; Masten L; Nistri A; Giniatullin R
Br J Pharmacol; 2004 Mar; 141(6):1048-58. PubMed ID: 14980981
[TBL] [Abstract][Full Text] [Related]
5. The P2X3 antagonist P1, P5-di[inosine-5'] pentaphosphate binds to the desensitized state of the receptor in rat dorsal root ganglion neurons.
Ford KK; Matchett M; Krause JE; Yu W
J Pharmacol Exp Ther; 2005 Oct; 315(1):405-13. PubMed ID: 16014755
[TBL] [Abstract][Full Text] [Related]
6. [3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors.
Jarvis MF; Bianchi B; Uchic JT; Cartmell J; Lee CH; Williams M; Faltynek C
J Pharmacol Exp Ther; 2004 Jul; 310(1):407-16. PubMed ID: 15024037
[TBL] [Abstract][Full Text] [Related]
7. Flexible subunit stoichiometry of functional human P2X2/3 heteromeric receptors.
Kowalski M; Hausmann R; Schmid J; Dopychai A; Stephan G; Tang Y; Schmalzing G; Illes P; Rubini P
Neuropharmacology; 2015 Dec; 99():115-30. PubMed ID: 26184350
[TBL] [Abstract][Full Text] [Related]
8. A hydrophobic residue in position 15 of the rP2X3 receptor slows desensitization and reveals properties beneficial for pharmacological analysis and high-throughput screening.
Hausmann R; Bahrenberg G; Kuhlmann D; Schumacher M; Braam U; Bieler D; Schlusche I; Schmalzing G
Neuropharmacology; 2014 Apr; 79():603-15. PubMed ID: 24452010
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.
Spelta V; Jiang LH; Surprenant A; North RA
Br J Pharmacol; 2002 Mar; 135(6):1524-30. PubMed ID: 11906966
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of cloned P2X receptors.
North RA; Surprenant A
Annu Rev Pharmacol Toxicol; 2000; 40():563-80. PubMed ID: 10836147
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Ca2+ influx through recombinant P2X receptor in C6BU-1 cells.
Ueno S; Koizumi S; Inoue K
Br J Pharmacol; 1998 Aug; 124(7):1484-90. PubMed ID: 9723962
[TBL] [Abstract][Full Text] [Related]
12. Mechanical allodynia caused by intraplantar injection of P2X receptor agonist in rats: involvement of heteromeric P2X2/3 receptor signaling in capsaicin-insensitive primary afferent neurons.
Tsuda M; Koizumi S; Kita A; Shigemoto Y; Ueno S; Inoue K
J Neurosci; 2000 Aug; 20(15):RC90. PubMed ID: 10899177
[TBL] [Abstract][Full Text] [Related]
13. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
[TBL] [Abstract][Full Text] [Related]
14. Guinea-pig sympathetic neurons express varying proportions of two distinct P2X receptors.
Zhong Y; Dunn PM; Burnstock G
J Physiol; 2000 Mar; 523 Pt 2(Pt 2):391-402. PubMed ID: 10699083
[TBL] [Abstract][Full Text] [Related]
15. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
De Roo M; Boué-Grabot E; Schlichter R
Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
[TBL] [Abstract][Full Text] [Related]
16. TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics.
Honore P; Mikusa J; Bianchi B; McDonald H; Cartmell J; Faltynek C; Jarvis MF
Pain; 2002 Mar; 96(1-2):99-105. PubMed ID: 11932066
[TBL] [Abstract][Full Text] [Related]
17. The antagonist trinitrophenyl-ATP reveals co-existence of distinct P2X receptor channels in rat nodose neurones.
Thomas S; Virginio C; North RA; Surprenant A
J Physiol; 1998 Jun; 509 ( Pt 2)(Pt 2):411-7. PubMed ID: 9575290
[TBL] [Abstract][Full Text] [Related]
18. ATP analogues with modified phosphate chains and their selectivity for rat P2X2 and P2X2/3 receptors.
Spelta V; Mekhalfia A; Rejman D; Thompson M; Blackburn GM; North RA
Br J Pharmacol; 2003 Nov; 140(6):1027-34. PubMed ID: 14581175
[TBL] [Abstract][Full Text] [Related]
19. Desensitization masks nanomolar potency of ATP for the P2X1 receptor.
Rettinger J; Schmalzing G
J Biol Chem; 2004 Feb; 279(8):6426-33. PubMed ID: 14625300
[TBL] [Abstract][Full Text] [Related]
20. Characterization of P2X3, P2Y1 and P2Y4 receptors in cultured HEK293-hP2X3 cells and their inhibition by ethanol and trichloroethanol.
Fischer W; Wirkner K; Weber M; Eberts C; Köles L; Reinhardt R; Franke H; Allgaier C; Gillen C; Illes P
J Neurochem; 2003 May; 85(3):779-90. PubMed ID: 12694404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
